Ashley Birkett | Global Head, Malaria Vaccines and Biologics

Ashley Birkett, Global Head, Malaria Vaccines and Biologics, PATH

Ashley Birkett is the Global Head of Malaria within PATH’s Center for Vaccine Innovation and Access (CVIA) and serves on the CVIA Leadership Team. CVIA brings together expertise across every stage of vaccine research, development, and introduction to make vaccines globally available to women, children, and communities, particularly in low resource settings. He oversees the development and implementation of the malaria program’s strategy, including programmatic, administrative, and financial management aspects, to develop new models and explore new pathways to accelerate the development and introduction of malaria biologics. CVIA’s malaria portfolio encompasses partnered vaccines and monoclonal antibodies at various stages of development, from preclinical through introduction, and is supported by donors in the US, Europe and Asia. He has 25 years of development experience, initially with biotechnology companies, where he successfully advanced novel influenza and malaria vaccine candidates from research through first-in-human clinical studies. Ashley earned a PhD in biochemistry and molecular biophysics from Virginia Commonwealth University.


WVIC/WAC Day 2 - Nov 30 @ 09:00

Global Health Goals – can we get back on track?

  • How has the pandemic affected the status of the epidemics of tuberculosis, malaria and neglected tropical diseases?
  • Silver linings – new investments in immunization infrastructure – understanding of barriers and opportunities in promoting vaccination within communities and countries. How do we try to capitalize on some of the new pathways generated because of covid?
  • How will malaria vaccines be implemented? How does this vaccine need to be promoted differently to previous vaccines? How to communicate value of vaccines in burdened communities. Integrated strategy required.
  • TB vaccines how are we moving forward? Next steps for TB vaccines.
last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall